FIRST WAVE BIOPHARMA, INC.

Analyst Reco. First Wave BioPharma, Inc.

Equities

FWBI

US33749P4081

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
2.74 ^USD	+0.37%		+5.38%	-34.76%

03-29	First Wave BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-14	Sector Update: Health Care Stocks Retreating Late Afternoon	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Downgrades First Wave BioPharma to Neutral From Buy	14/07/23	MT
May CPI Inflation Slows in Line With Analysts' Expectations, Driving Narrow Premarket Gains for US Equity Futures	13/06/23	MT
HC Wainwright Adjusts First Wave BioPharma Price Target to $10 From $14, Maintains Buy Rating	15/05/23	MT
HC Wainwright Adjusts First Wave BioPharma Price Target to $14 From $18, Maintains Buy Rating	05/04/23	MT
HC Wainwright Reiterates First Wave BioPharma at Buy With $18 Price Target	03/02/23	MT
HC Wainwright Adjusts First Wave BioPharma's Price Target to $4 From $8, Keeps Buy Rating	02/12/22	MT
Roth Capital Adjusts First Wave BioPharma's Price Target to $9 from $20, Keeps Buy Rating	26/05/22	MT
Maxim Downgrades First Wave BioPharma to Hold From Buy	07/12/21	MT
AZURRX BIOPHARMA : Roth Capital Adjusts Price Target on AzurRx BioPharma to $5 From $7, Maintains Buy Rating	01/04/21	MT
AZURRX BIOPHARMA : HC Wainwright Adjusts Price Target on AzurRx BioPharma to $2.50 From $3.50, Maintains Buy Rating	01/04/21	MT
AZURRX BIOPHARMA : HC Wainwright Adjusts Price Target on AzurRx BioPharma to $3.50 From $2, Reiterates Buy Rating	10/02/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer